"Parents always ask why their child has developed leukemia, and unfortunately we have had few answers," says senior author Todd Druley, a Washington University pediatric oncologist who treats patients at St. Louis Children's Hospital. "Our study suggests that babies with leukemia inherit a strong genetic predisposition to the disease." (Credit: Nate/Flickr)

Infants with leukemia may inherit risk from both parents

Babies who develop leukemia during the first year of life appear to have inherited an unfortunate combination of genes from both parents that may make them highly susceptible to the disease.

Doctors have long puzzled over why it is that babies just a few months old sometimes develop cancer. As infants, they have not lived long enough to accumulate a critical number of cancer-causing mutations.

“Parents always ask why their child has developed leukemia, and unfortunately we have had few answers,” says senior author Todd Druley, a Washington University pediatric oncologist who treats patients at St. Louis Children’s Hospital. “Our study suggests that babies with leukemia inherit a strong genetic predisposition to the disease.”

The research, conducted at Washington University School of Medicine in St. Louis and the University of Minnesota, is available online in the journal Leukemia.

The babies appear to have inherited rare genetic variants from both parents that by themselves would not cause problems, but in combination put the infants at high risk of leukemia. These variants most often occurred in genes known to be linked to leukemia in children, says Druley, an assistant professor of pediatrics.

Leukemia occurs rarely in infants, with only about 160 cases diagnosed annually in the United States. But unlike leukemia in children, which most often can be cured, about half of infants who develop leukemia die of the disease.

DNA testing

The researchers sequenced all the genes in the DNA of healthy cells from 23 infants with leukemia and their mothers. Looking at genes in the healthy cells helped the researchers understand which genetic variations were passed from a mother to her child, and by process of elimination, the scientists could determine the father’s contribution to a baby’s DNA.

Among the families studied, there was no history of pediatric cancers. The scientists also sequenced the DNA of 25 healthy children as a comparison.

“We sequenced every single gene and found that infants with leukemia were born with an excess of damaging changes in genes known to be linked to leukemia,” Druley says. “For each child, both parents carried a few harmful genetic variations in their DNA, and just by chance their child inherited all of these changes.”

Other children in the families typically don’t develop leukemia because a roll of the genetic dice likely means they did not inherit the same combination of harmful genetic changes, he added.

Druley says it’s unlikely that the inherited variations alone cause cancer to develop in infants. Rather, the babies likely only needed to accumulate very few additional genetic errors in cells of the bone marrow, where leukemia originates, to develop the cancer in such a short time span.

Genetic editing

He and his colleagues now want to study the inherited variations in more detail to understand how they contribute to the development of leukemia. Eventually, with additional research, it may be possible to use a technique called genetic editing to “cut” the harmful gene from the DNA of infants who are susceptible to leukemia and replace it with a healthy version of the same gene, thereby sparing babies and their families from a devastating diagnosis.

The Children’s Discovery Institute at Washington University School of Medicine and St. Louis Children’s Hospital, National Institutes of Health, National Cancer Institute, Alex’s Lemonade Stand “A” Award, the Hyundai Hope Award, the Eli Seth Matthews Leukemia Foundation, and the Children Cancer Research Fund supported the research.

Source: Washington University in St. Louis

chat0 Comments

You are free to share this article under the Creative Commons Attribution-NoDerivs 3.0 Unported license.

0 Comments

We respect your privacy.